T. Rowe Price Associates »

Mural Oncology shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Mural Oncology (MURA) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Mural Oncology

Tip: Access up to 7 years of quarterly data

All positions including Mural Oncology held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mural Oncology by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $118k 38k 3.13
2024-06-30 $119k 38k 3.16
2024-03-31 $204k 42k 4.90
2023-12-31 $154k 26k 5.92

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Nvidia Corporation Comm Stk (NVDA)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOGL)
Unitedhealth Group Comm Stk (UNH)
Alphabet Comm Stk (GOOG)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Netflix Comm Stk (NFLX)
Tesla Comm Stk (TSLA)
Intuitive Surgical Comm Stk (ISRG)
Thermo Fisher Scientific Comm Stk (TMO)

View all positions for T. Rowe Price Associates

Top funds holding Mural Oncology

Newtyn Management
Acadian Asset Management
BlackRock
Centiva Capital
Renaissance Technologies
Geode Capital Management
PRIMECAP Management Company
Point72 Asset Management
Nicollet Investment Management
Susquehanna International
Krensavage Asset Management
T. Rowe Price Associates
Northern Trust
Standard Life Aberdeen
Bnp Paribas Arbitrage, Snc

View all funds holding Mural Oncology